This lecture fulfills part of the podiatric Infection Control and Risk Management continuing education requirement for both New York and Missouri, and is an important Risk Management topic for Mississippi, Nebraska, Nevada, New Hampshire, Arizona, Georgia, Kanas, Montana, and Pennsylvania as these states specifically outline in their practice act and/or practice rules that not adhering to proper infection control protocols and procedures is an infraction of such laws and rules and is considered unprofessional and unethical behavior (as of 2021). (Podiatry CME State Requirements for updates). Risk Management typically includes strategies for avoiding medical errors as well as studies in practicing medicine in an ethical manner. This presentation is Part 1 of 2 and focuses on the central theme of infection control data to ensure patient safety and how to provide a clean and infection free environment in your practice. An appraisal of infection control strategies and mitigating tools for the podiatric physician is grounded in clinical base statistics as well as reports from medical text and best practice guidelines; so that the physician may develop mitigating tools to avoid exposing their patients to contiguous disease. The goal of these 2-hour long presentations is to fulfill 2 hours of the CME requirement for podiatric physicians.
CME (Credits: 1)
Complete the 4 steps to earn your CE/CME credit:
PRESENT e-Learning Systems is approved by the Council on Podiatric Medical Education as a provider of continuing education in podiatric medicine. PRESENT e-Learning Systems has approved this activity for a maximum of 1 continuing education contact hours
Release Date: 03/07/2022 Expiration Date: 03/07/2023
To view Lectures online, the following specs are required:
It is the policy of PRESENT e-Learning Systems and it's accreditors to insure balance, independence, objectivity and scientific rigor in all its individually sponsored or jointly sponsored educational programs. All faculty participating in any PRESENT e-Learning Systems sponsored programs are expected to disclose to the program audience any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic. The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified openly so that the listeners may form their own judgments about the presentation with the full disclosure of the facts.---
Robert Smith has nothing to disclose.